SCHEMBL15978282

SCHEMBL15978282

CC(C)c1cc(O)c(C=O)cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.53
LMNA P02545 2/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
TRPA1 O75762 1/20 0.41
CHRM1 P11229 1/20 0.41
SLC6A2 P23975 1/20 0.41
ADRA1A P35348 1/20 0.41
HTR2B P41595 1/20 0.41
ERN1 O75460 5/20 0.40
TRIM24 O15164 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40
PKM P14618 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29973971 0.92 TYR (0.53) TYRLMNAHSP90AA1HSP90AB1TRPA1
SCHEMBL723126 0.92 TYR (0.53) TYRLMNAHSP90AA1HSP90AB1TRPA1
Hydrochloric Acid SCHEMBL28927068 0.90 TYR (0.52) TYRLMNAHSP90AA1HSP90AB1TRPA1
SCHEMBL18415735 0.84 LMNA (0.48) TYRLMNAHSP90AA1HSP90AB1TRPA1
SCHEMBL3379260 0.80 LMNA (0.53) TYRLMNATRPA1CHRM1SLC6A2
SCHEMBL14223114 0.80 MAPT (0.42) TYRLMNAHSP90AA1HSP90AB1TRPA1
SCHEMBL18430735 0.80 ALDH1A1 (0.53) TYRLMNAERN1TRIM24TRIM33
SCHEMBL4289408 0.79 ERN1 (0.54) TYRERN1TRIM24TRIM33PIM1
SCHEMBL67859 0.79 LMNA (0.58) LMNAHSP90AA1HSP90AB1TRPA1CHRM1
SCHEMBL23094609 0.79 TYR (0.44) TYRLMNAHSP90AA1HSP90AB1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140243404-A1 UNIQUE HALOGEN-INDUCED CYCLIZATIONS, REAGENTS THEREFOR, AND COMPOUNDS PRODUCED THEREBY THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243404-A1 UNIQUE HALOGEN-INDUCED CYCLIZATIONS, REAGENTS THEREFOR, AND COMPOUNDS PRODUCED THEREBY WEE1, WEE2, NOTUM TYR 1160/4885LMNA 3378/4885HSP90AA1 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.